IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $52,560 | +14.8% | 1,281 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $45,783 | -5.4% | 1,281 | 0.0% | 0.01% | -10.0% |
Q4 2022 | $48,383 | -15.1% | 1,281 | 0.0% | 0.01% | -23.1% |
Q3 2022 | $57,000 | +21.3% | 1,281 | 0.0% | 0.01% | +30.0% |
Q2 2022 | $47,000 | 0.0% | 1,281 | 0.0% | 0.01% | +11.1% |
Q1 2022 | $47,000 | +20.5% | 1,281 | 0.0% | 0.01% | +12.5% |
Q4 2021 | $39,000 | -9.3% | 1,281 | 0.0% | 0.01% | -20.0% |
Q3 2021 | $43,000 | -15.7% | 1,281 | 0.0% | 0.01% | -16.7% |
Q2 2021 | $51,000 | -28.2% | 1,281 | -19.0% | 0.01% | -33.3% |
Q1 2021 | $71,000 | -37.2% | 1,581 | -21.2% | 0.02% | -43.8% |
Q4 2020 | $113,000 | +18.9% | 2,006 | 0.0% | 0.03% | +6.7% |
Q3 2020 | $95,000 | -19.5% | 2,006 | 0.0% | 0.03% | -28.6% |
Q2 2020 | $118,000 | -2.5% | 2,006 | 0.0% | 0.04% | -2.3% |
Q1 2020 | $121,000 | 0.0% | 2,006 | 0.0% | 0.04% | +2.4% |
Q4 2019 | $121,000 | +0.8% | 2,006 | 0.0% | 0.04% | -6.7% |
Q3 2019 | $120,000 | +2.6% | 2,006 | +9.9% | 0.04% | +2.3% |
Q2 2019 | $117,000 | -20.9% | 1,825 | 0.0% | 0.04% | -27.9% |
Q1 2019 | $148,000 | +43.7% | 1,825 | -3.9% | 0.06% | +27.1% |
Q4 2018 | $103,000 | +5.1% | 1,900 | 0.0% | 0.05% | +20.0% |
Q3 2018 | $98,000 | +24.1% | 1,900 | 0.0% | 0.04% | +14.3% |
Q2 2018 | $79,000 | -6.0% | 1,900 | 0.0% | 0.04% | 0.0% |
Q1 2018 | $84,000 | -12.5% | 1,900 | 0.0% | 0.04% | -7.9% |
Q4 2017 | $96,000 | 0.0% | 1,900 | 0.0% | 0.04% | -5.0% |
Q3 2017 | $96,000 | -1.0% | 1,900 | 0.0% | 0.04% | -9.1% |
Q2 2017 | $97,000 | +27.6% | 1,900 | 0.0% | 0.04% | +22.2% |
Q1 2017 | $76,000 | -16.5% | 1,900 | 0.0% | 0.04% | -20.0% |
Q4 2016 | $91,000 | +30.0% | 1,900 | 0.0% | 0.04% | +28.6% |
Q3 2016 | $70,000 | +59.1% | 1,900 | 0.0% | 0.04% | +52.2% |
Q2 2016 | $44,000 | -42.9% | 1,900 | 0.0% | 0.02% | -46.5% |
Q1 2016 | $77,000 | -34.7% | 1,900 | 0.0% | 0.04% | -33.8% |
Q4 2015 | $118,000 | – | 1,900 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |